Home › Trial NCT07653438
In Vivo Fluorescence Molecular Bronchoscopy of Durvalumab-680LT in Patients With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) After Chemoradiotherapy
- Trial IDNCT07653438
- StatusNot Yet Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorUniversity Medical Center Groningen
- Enrollment20
- Start date2026-09-01
- ConditionsStage III Non-small Cell Lung Cancer · Unresectable Stage III NSCLC
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.